ad image

Drug Screening

1 / 1
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

PAO-02-21-CL-04Feb 18, 2021
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

PA1081Jan 26, 2021
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Ron Laethem, Ph.D.

Altis Biosystems

PAO-11-20-CL-01Dec 09, 2020
Evaluating Microbiome Therapies with Intestinal Cell Models
Microbiome

Evaluating Microbiome Therapies with Intestinal Cell Models

Scott Magness, Ph.D.

Altis Biosystems

PAO-10-20-CL-02Oct 22, 2020
Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models
Organ-on-a-Chip

Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models

Gustavo Mahler, Ph.D.; Jessica Davis

Dynamk Capital

PAP-Q3-20-CL-014Sep 29, 2020
Accelerating Drug Development with Microphysiological Systems (MPS)
Microphysiological Systems

Accelerating Drug Development with Microphysiological Systems (MPS)

Nancy Allbritton, Ph.D., M.D.

Altis Biosystems

PAP-Q3-20-CL-003Sep 29, 2020
Overcoming Skin Assay Challenges with Living Human Models
Skin Models

Overcoming Skin Assay Challenges with Living Human Models

Pascal Descargues, Ph.D.

Genoskin

PAP-Q3-20-CL-017Sep 29, 2020
1 / 1